The insulin-loaded TTA-DFP-nCOF successfully crossed the intestinal barrier and sustainably reduced the blood glucose level in vivo in type 1 diabetic (T1D) rat model with the glucose level completely returning to normal as compared to the non-diabetic control group without inducing systemic toxicity. The gene discussed is INS; the disease is type 1 diabetes mellitus.